Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Is Towa’s Guidance For 2024 ‘Somewhat Mediocre?’

One Leading Market Analyst Unimpressed With Operating Profit Guide

22 May 2024

• By Dean Rudge

Japan q1 round up — • Source: Shutterstock

Related Content

Teva Exits Japanese Generics With Plan To Sell Local Business

09 May 2024

Japan Drug Price Revision: Cuts, Increases Aim To Balance National Healthcare Costs

15 Mar 2024

Japan Results Roundup: Weak Yen Provides A Boost But Some Sales Challenges Emerge

02 May 2024

Related Companies

Towa Pharmaceutical Co Ltd

More from Archive

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.